KasiskeB.L.Risk factors for accelerated atherosclerosis in renal transplant patients.Am J Med1988; 84: 985–92.
2.
LindholmA., AlbrechtsenD., FrodinL., TufvesonG., PerssonN.H., LundgrenG.Ischemic heart disease— major cause of death and graft loss after transplantation in Scandinavia.Transplantation1995; 60: 451–7.
3.
WilsonP., D'AgostinoR., LevyD., BelangerA., SilbershatzH., KannellW.Prediction of coronary heart disease using risk factor categories.Circulation1998; 97: 1837–47.
4.
HutingJ., KramerW., SchutterleG., WizemannV.Analysis of left ventricular changes associated with chronic hemodialysis. A non-invasive follow-up study.Nephron1988; 49: 284–90.
5.
ParfreyP.S., FoleyR.N., HarnettJ.D., KentG.M., MurrayD.C., BarréP.E.The outcome and risk factors for left ventricular disorders in chronic uraemia.Nephrol Dial Transplant1996; 11: 1277–85.
6.
FoleyR.N., ParfreyP.S., HarnettJ.D., KentG.M., MurrayD.C., BarréP.E.The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease.Am J Kidney Dis1996; 28: 53–61.
7.
LevinA., ThompsonC.R., EthierJ., CarlisleE.J., TobeS., MendelssohnD.Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.Am J Kidney Dis1999; 34: 125–34.
8.
ParfreyP.S., FoleyR.N., HarnettJ.D., KentG.M., MurrayD., BarréP.E.Outcome and risk factors of ischemic heart disease in chronic uremia.Kidney Int1996; 49: 1428–34.
9.
ParfreyP.S., HarnettJ.D., FoleyR.N., KentG.M., MurrayD.C., BarréP.E.Impact of renal transplantation on uremic cardiomyopathy.Transplantation1995; 60: 908–14.
10.
RigattoC., FoleyR.N., KentG.M., GuttmannR., ParfreyP.S.Long-term changes in left ventricular hypertrophy after renal transplantation.Transplantation2000; 70: 570–5.
11.
SenniM., TribouilloyC.M., RodehefferR.J., JacobsenS.J., EvansJ.M., BaileyK.R.Congestive heart failure in the community: trends in incidence and survival in a 10-year period.Arch Intern Med1999; 159: 29–34.
12.
HoK., PinskyJ., KannelW., LevyD.The epidemiology of heart failure: the Framingham Study.J Am Coll Cardiol1993; 22: 6A–13A.
13.
KasiskeB.L., GuijarroC., MassyZ.A., WiederkehrM.R., MaJ.Z.Cardiovascular disease after renal transplantation.J Am Soc Nephrol1996; 7: 158–65.
14.
LazarusJ.M., BourgoignieJ.J., BuckalewV.M., GreeneT., LeveyA.S., MilasN.C.Achievement and safety of a low blood pressure goal in chronic renal disease. the Modification of Diet in Renal Disease Study Group.Hypertension1997; 29: 641–50.
15.
MaschioG., AlbertiD., JaninG., LocatelliF., MannJ.F., MotoleseM.Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.N Engl J Med1996; 334: 939–45.
16.
CulletonB.F., LarsonM.G., WilsonP.W.F., EvanJ.C., ParfreyP.S., LevyD.Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.Kidney Int1999; 56: 2214–19.
DuclouxD., MotteG., ChallierB., GibeyR., ChalopinJ.M.Serum total homocysteine and cardiovascular disease occurrence in chronic stable transplant recipients: a prospective study.J Am Soc Nephrol2000; 11: 134–7.
20.
KasiskeB., HariniC., RoelJ.Explained and unexplained ischemic heart disease risk after renal transplantation.J Am Soc Nephrol2000; 11: 1735–43.
FoleyR., ParfreyP., SarnakM.Epidemiology of cardiovascular disease in chronic renal disease.J Am Soc Nephrol1998; 9: S16–23.
24.
KasiskeB.Hyperlipidemia with chronic renal disease.Am J Kidney Dis1998; 32: S142–56.
25.
MaillouxL., LeveyA.Hypertension in patients with chronic renal disease.Am J Kidney Dis1998; 32: S120–41.
26.
MannJ F., GersteinH.C., PogueJ., BoschJ., YusufS.Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE Randomized Trial.Ann Intern Med2001; 134: 707–9.
27.
van Ypersele de StrihouC.Should anaemia in subtypes of CRF patients be managed differently?Nephrol Dial Transplant1999; 14: S37–45.
